
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers
Arne Gessner, Anna Gemeinhardt, Agnes Bosch, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Arne Gessner, Anna Gemeinhardt, Agnes Bosch, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Showing 6 citing articles:
Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction
Pasquale Mone, Angela Lombardi, Jessica Gambardella, et al.
Diabetes Care (2022) Vol. 45, Iss. 5, pp. 1247-1251
Open Access | Times Cited: 109
Pasquale Mone, Angela Lombardi, Jessica Gambardella, et al.
Diabetes Care (2022) Vol. 45, Iss. 5, pp. 1247-1251
Open Access | Times Cited: 109
L-Arginine in diabetes: clinical and preclinical evidence
Imma Forzano, Roberta Avvisato, Fahimeh Varzideh, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 40
Imma Forzano, Roberta Avvisato, Fahimeh Varzideh, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 40
Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes
Shujun Zhang, Fen Wang, Lei Xie, et al.
Journal of Diabetes Investigation (2024)
Open Access | Times Cited: 1
Shujun Zhang, Fen Wang, Lei Xie, et al.
Journal of Diabetes Investigation (2024)
Open Access | Times Cited: 1
Biomarkers navigate drug development: Pharmacology, effectiveness and safety
Daohong Chen
Medicine in Drug Discovery (2023) Vol. 21, pp. 100174-100174
Open Access | Times Cited: 3
Daohong Chen
Medicine in Drug Discovery (2023) Vol. 21, pp. 100174-100174
Open Access | Times Cited: 3
Asymmetric Dimethylarginine as a Biomarker in Coronary Artery Disease
Νικόλαος Παπαγεωργίου, Panagiotis Theofilis, Evangelos Oikonomou, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 23, Iss. 6, pp. 470-480
Closed Access | Times Cited: 5
Νικόλαος Παπαγεωργίου, Panagiotis Theofilis, Evangelos Oikonomou, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 23, Iss. 6, pp. 470-480
Closed Access | Times Cited: 5
Effect of dapagliflozin on readmission and loop diuretics use in patients with acute heart failure: a retrospective propensity score-matched cohort study
Dong Wu, Zhen Ma, Xiaoying Wang, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access
Dong Wu, Zhen Ma, Xiaoying Wang, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access